S&P 500   5,011.12 (-0.22%)
DOW   37,775.38 (+0.06%)
QQQ   423.41 (-0.57%)
AAPL   167.04 (-0.57%)
MSFT   404.27 (-1.84%)
META   501.80 (+1.54%)
GOOGL   156.01 (+0.35%)
AMZN   179.22 (-1.14%)
TSLA   149.93 (-3.55%)
NVDA   846.71 (+0.76%)
AMD   155.08 (+0.69%)
NIO   4.00 (+2.30%)
BABA   68.88 (+0.09%)
T   16.33 (+1.30%)
F   12.06 (+0.17%)
MU   111.93 (-3.78%)
GE   152.94 (-1.75%)
CGC   7.83 (+20.65%)
DIS   112.43 (-0.45%)
AMC   2.92 (-2.01%)
PFE   25.39 (-0.12%)
PYPL   62.10 (-1.83%)
XOM   118.52 (-0.09%)
S&P 500   5,011.12 (-0.22%)
DOW   37,775.38 (+0.06%)
QQQ   423.41 (-0.57%)
AAPL   167.04 (-0.57%)
MSFT   404.27 (-1.84%)
META   501.80 (+1.54%)
GOOGL   156.01 (+0.35%)
AMZN   179.22 (-1.14%)
TSLA   149.93 (-3.55%)
NVDA   846.71 (+0.76%)
AMD   155.08 (+0.69%)
NIO   4.00 (+2.30%)
BABA   68.88 (+0.09%)
T   16.33 (+1.30%)
F   12.06 (+0.17%)
MU   111.93 (-3.78%)
GE   152.94 (-1.75%)
CGC   7.83 (+20.65%)
DIS   112.43 (-0.45%)
AMC   2.92 (-2.01%)
PFE   25.39 (-0.12%)
PYPL   62.10 (-1.83%)
XOM   118.52 (-0.09%)
S&P 500   5,011.12 (-0.22%)
DOW   37,775.38 (+0.06%)
QQQ   423.41 (-0.57%)
AAPL   167.04 (-0.57%)
MSFT   404.27 (-1.84%)
META   501.80 (+1.54%)
GOOGL   156.01 (+0.35%)
AMZN   179.22 (-1.14%)
TSLA   149.93 (-3.55%)
NVDA   846.71 (+0.76%)
AMD   155.08 (+0.69%)
NIO   4.00 (+2.30%)
BABA   68.88 (+0.09%)
T   16.33 (+1.30%)
F   12.06 (+0.17%)
MU   111.93 (-3.78%)
GE   152.94 (-1.75%)
CGC   7.83 (+20.65%)
DIS   112.43 (-0.45%)
AMC   2.92 (-2.01%)
PFE   25.39 (-0.12%)
PYPL   62.10 (-1.83%)
XOM   118.52 (-0.09%)
S&P 500   5,011.12 (-0.22%)
DOW   37,775.38 (+0.06%)
QQQ   423.41 (-0.57%)
AAPL   167.04 (-0.57%)
MSFT   404.27 (-1.84%)
META   501.80 (+1.54%)
GOOGL   156.01 (+0.35%)
AMZN   179.22 (-1.14%)
TSLA   149.93 (-3.55%)
NVDA   846.71 (+0.76%)
AMD   155.08 (+0.69%)
NIO   4.00 (+2.30%)
BABA   68.88 (+0.09%)
T   16.33 (+1.30%)
F   12.06 (+0.17%)
MU   111.93 (-3.78%)
GE   152.94 (-1.75%)
CGC   7.83 (+20.65%)
DIS   112.43 (-0.45%)
AMC   2.92 (-2.01%)
PFE   25.39 (-0.12%)
PYPL   62.10 (-1.83%)
XOM   118.52 (-0.09%)
Free Trial
LON:ABC

Abcam (ABC) Share Price, News & Analysis

→ The Next Nvidia? (From InvestorPlace) (Ad)
Free ABC Stock Alerts
GBX 1,226
+123.00 (+11.15%)
(As of 12/13/2022)
Compare
Today's Range
1,115
▼
1,259
50-Day Range
1,226
▼
1,226
52-Week Range
1,013.57
▼
1,760
Volume
6.37 million shs
Average Volume
392,791 shs
Market Capitalization
£2.81 billion
P/E Ratio
20,433.33
Dividend Yield
0.91%
Price Target
N/A
Stock Analysis
Stock Analysis
ABC stock logo

About Abcam Stock (LON:ABC)

Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include cytokines; edited cell lines and lysates; and various other products, including cellular activity kits, miRNA kits, biochemicals, and cell signaling pathway tools. The company serves scientists and researchers in academic institutions and research institutes, as well as in pharmaceutical, biotechnology, and diagnostics companies. It has operations in the Americas, Europe, the Middle East, Africa, China, Japan, and rest of the Asia Pacific. The company sells its products online. Abcam plc was incorporated in 1998 and is headquartered in Cambridge, the United Kingdom.

ABC Stock Price History

ABC Stock News Headlines

April 16, 2024 | msn.com
Researchers discover cause of rare congenital lung malformations
April 10, 2024 | americanbankingnews.com
Abcam (LON:ABC) Stock Passes Below Two Hundred Day Moving Average of $1,226.00
April 18, 2024 | InvestorPlace (Ad)
The Next Nvidia?
The Next Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the next Nvidia. Few in the media are talking about this story yet… but in the next 6 months that’s all they’ll talk about.
April 9, 2024 | finance.yahoo.com
DNA Methylation Market Analysis 2024-2032 by Product, Technology, Application, End User, and Region - Industry to Rise at a 13.9% CAGR
March 27, 2024 | finanznachrichten.de
Cell Culture Market Worth $57.9 billion | MarketsandMarkets
March 25, 2024 | uk.finance.yahoo.com
Global Research Antibodies Market Projected to Reach $5.5 Billion by 2030, Driven by Advances in Personalized Medicine
March 18, 2024 | sg.finance.yahoo.com
Super Micro Computer, Deckers Outdoor make S&P 500 debut
February 25, 2024 | msn.com
Bill Gates' 16 Dividend Stocks To Buy
April 18, 2024 | InvestorPlace (Ad)
The Next Nvidia?
The Next Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the next Nvidia. Few in the media are talking about this story yet… but in the next 6 months that’s all they’ll talk about.
February 21, 2024 | uk.finance.yahoo.com
3D Cell Cultures Market 2024-2028: Global Demand for 3D Cell Culture Solutions Surges with Expanding Biotechnology Applications
February 19, 2024 | msn.com
Why science parks are important
February 14, 2024 | finance.yahoo.com
Danaher Corporation: Reaffirming BUY, raising target to $285
February 5, 2024 | finanznachrichten.de
Recombinant Proteins Market Worth $3.2 Billion | MarketsandMarkets.
February 5, 2024 | uk.finance.yahoo.com
Danaher Launches Collaboration with Cincinnati Children's Hospital Medical Center Aiming to Improve Patient Safety in Early Drug Development
February 3, 2024 | seekingalpha.com
Danaher: Better Positioned For The Future
February 2, 2024 | finance.yahoo.com
Top Stock Reports for Eli Lilly, Danaher & Citigroup
February 1, 2024 | finanznachrichten.de
Lazard Reports Fourth-Quarter and Full-Year 2023 Results
January 30, 2024 | finanznachrichten.de
Danaher Corporation: Danaher Reports Fourth Quarter and Full Year 2023 Results
January 30, 2024 | reuters.com
Danaher forecasts revenue decline in 2024, shares fall
January 29, 2024 | msn.com
Another UK snub: Cambridge spin-out eyes New York IPO as unicorn status beckons
January 26, 2024 | bizjournals.com
Here's how a bite-sized merger deal between two Reston-based contractors benefitted both
January 23, 2024 | finance.yahoo.com
Research Antibodies Global Market Analysis to 2030: Focus on Monoclonal Antibodies, Rising Demand in North America, Strategies of Leading Players
January 23, 2024 | ca.finance.yahoo.com
DHR Sep 2024 210.000 call
January 19, 2024 | finance.yahoo.com
Danaher Corporation (DHR) Completed the Acquisition of Abcam
January 14, 2024 | uk.finance.yahoo.com
Abcam PLC (A8C3.MU)
January 9, 2024 | finanznachrichten.de
Danaher Corporation: Danaher CEO to Comment on Financial Performance
January 9, 2024 | msn.com
Danaher gives Q4 guidance, expects low double-digit drop in revenue
See More Headlines
Receive ABC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Abcam and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
LON:ABC
CUSIP
N/A
CIK
N/A
Web
www.abcam.com
Phone
+44-1223-696000
Fax
N/A
Employees
1,650
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
20,433.33
Forward P/E Ratio
33.28
P/E Growth
1.57
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
31.60
Current Ratio
1.27
Quick Ratio
0.89

Sales & Book Value

Annual Sales
£350.40 million
Price / Sales
8.02
Cash Flow
GBX 50.93 per share
Price / Cash Flow
24.07
Book Value
GBX 318.30 per share
Price / Book
3.85

Miscellaneous

Outstanding Shares
229,272,000
Free Float
N/A
Market Cap
£2.81 billion
Optionable
Not Optionable
Beta
N/A
7 Stocks to Own Before the 2024 Election Cover
7 Stocks to Own Before the 2024 Election

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Key Executives

  • Mr. Alan Thomas Hirzel BS (Age 54)
    M.B.A., M.S., MBA, MS, CEO & Exec. Director
    Comp: $1.23M
  • Mr. Michael Shaun Baldock B.A. (Age 58)
    CFO & Director
    Comp: $881.14k
  • Mr. Mark Dermody
    Interim CIO
  • James Staveley
    VP of Investor Relations
  • Marc Perkins
    Gen. Counsel & Company Sec.
  • Emma Sceats
    Sr. VP of Sales, Service & Bus. Devel.
  • Mr. Nick Skinner
    Sr. VP of HR
  • Mr. Mark Bushfield
    Sr. VP of Research & Innovation
  • Ms. Kirstie Speck BBusSc
    Head of Consumer Insights
  • Ms. Yvonne Chien
    Sr. VP of Customer Experience

Key Competitors

View All Competitors

ABC Stock Analysis - Frequently Asked Questions

How have ABC shares performed in 2024?

Abcam's stock was trading at GBX 1,226 at the start of the year. Since then, ABC stock has increased by 0.0% and is now trading at GBX 1,226.
View the best growth stocks for 2024 here.

What other stocks do shareholders of Abcam own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Abcam investors own include Hawkins (HWKN), Xtrackers California Municipal Bond ETF (CA), Endologix (ELGX), BlackRock (BLK), Chipotle Mexican Grill (CMG), Aegean Marine Petroleum Network (ANW), Athabasca Oil (ATH), HSBC (HSBA), Royal Dutch Shell (RDSA) and Centrica (CNA).

How do I buy shares of Abcam?

Shares of ABC stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:ABC) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners
[Urgent!] Generational Wealth Gameplan
Crypto 101 Media
The “Perfect Storm” for Gold
Gold Safe Exchange
Biden’s $374B Giveaway Into This Sector
DTI
He Is Giving Away Bitcoin
Crypto Swap Profits
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS
Paradigm Press
Your Money is Not Safe
American Alternative
The Next Nvidia?
InvestorPlace
Top 5 AI Stocks to Buy for 2024
Market Moving Trends